TRANSKRANIELLE MAGNETSTIMULATORVORRICHTUNG

Patent europeic · EP4265294 · En vigur

Inscripziun en il register

Numer da publicaziun
EP4265294
Numer da la dumonda
EP21906481
Gener
Patent europeic cun effect per la Svizra ed il Liechtenstein
Status
En vigur
Scrittira da patent
Concedì
Annunzià
09-12-2021
Publitgà
25-10-2023
Concedì
08-07-2026
La protecziun finescha il pli tard
08-12-2041
Proxima taxa annuala scadenta
31-12-2026
Classas IPC
A61N 2/00 (2006.01)
A61N 2/10 (2006.01)
Prioritad
JP 2020208513 16.12.2020
Dumonda PCT
PCT/JP2021/045288 09.12.2021
Publicaziun PCT
WO2022/131118 23.06.2022
Lingua da l’annunzia
giapunais
Funtauna
Swissreg

Istorgia

Quai che l’Institut federal da la proprietad intellectuala ha publitgà davart quest titel, il pli nov l’emprim.

  1. 08-07-2026

    Concedì

    Specification status
    Non-published patent application → Granted patent
    Status of protective title
    Initiated → Active

    Published in Swissreg on 08.07.2026

Partidas

Possessur

Teijin Pharma Limited

2-1, Kasumigaseki 3-chome Chiyoda-ku, Tokyo 100-0013, JP

Inventur

NAKAMURA, Hitoshi

Tokyo 100-0013, JP

NANDOH, Kenji

Matsudo-shi, Chiba 270-0021, JP

Il register numna mintga partida cun num ed adressa. In possessur u in represchentant vegn collià cun in’organisaziun, sch’exact ina unitad giuridica dal register da commerzi porta ses num; la via d’ina partida betg enconuschida uschia na vegn betg mussada qua.